1-4 of 4
Roland Geisberger
Close
Sort by
Journal Articles

Lenalidomide/Rituximab Maintenance After Induction With Fludarabine/Rituximab In Combination With Escalating Doses Of Lenalidomide In Previously Untreated Chronic Lymphocytic Leukemia (CLL): The Revlirit CLL5 AGMT Phase I/II Study, Final Results

Alexander Egle, Michael Steurer, MD, Franz Josef Gassner, PhD, Roland Geisberger, Thomas Melchardt, MD, Lisa Pleyer, MD, DI, Lukas Weiss, MD, Michael A. Fridrik, MD, Josef Thaler, MD, Alois Lang, MD, Richard Greil, MD
Journal: Blood
Blood (2013) 122 (21): 4164.
https://doi.org/10.1182/blood.V122.21.4164.4164
Published: 2013
Journal Articles

Chronic Lymphocytic Leukemia Cells With Trisomy 12 Home To The Bone Marrow In a CXCR4-Independent Manner and Are Prone To Proliferate In Vitro

Evelyn Hutterer, Elisabeth Hinterseer, Sylvia Ganghammer, Gabriele Brachtl, Daniela Asslaber, Peter William Krenn, Tamara Girbl, Petra Berghammer, Roland Geisberger, Alexander Egle, Antonella Zucchetto, Valter Gattei, Alexandre Chigaev, Richard Greil, MD, Tanja Nicole Hartmann
Journal: Blood
Blood (2013) 122 (21): 870.
https://doi.org/10.1182/blood.V122.21.870.870
Published: 2013
Journal Articles

T Cell Exhaustion Contributes to Immune Evasion in Chronic Lymphocytic Leukaemia

Franz Josef Gassner, PhD, Nadja Zaborsky, PhD, Daniel Neureiter, MD, Michael Huemer, MSc, Alexander Egle, MD, Tanja Nicole Hartmann, PhD, Richard Greil, MD, Roland Geisberger, PhD
Journal: Blood
Blood (2012) 120 (21): 1773.
https://doi.org/10.1182/blood.V120.21.1773.1773
Published: 2012
Journal Articles

A Combination of Fludarabine/Rituximab with Escalating Doses of Lenalidomide in Previously Untreated Chronic Lymphocytic Leukemia (CLL): The REVLIRIT CLL5 AGMT Phase I/II Study, Clinical and Exploratory Analyses of Induction Results

Alexander Egle, MD, Michael Steurer, MD, Franz Gassner, Roland Geisberger, PhD, Thomas Melchardt, MD, Lukas Weiss, MD, Michael A. Fridrik, MD, Josef Thaler, MD, Alois Lang, MD, Richard Greil, MD
Journal: Blood
Blood (2011) 118 (21): 292.
https://doi.org/10.1182/blood.V118.21.292.292
Published: 2011